News & Updates

Treatment with low-dose spironolactone results in reduced albuminuria without causing hyperkalaemia in patients with type 2 diabetes (T2D), reports a study.

Individuals with higher genetically predicted plasma cortisol appear to have greater odds of hypertension, according to a Mendelian randomization analysis.

Assessment of apparent strong ion difference (aSID), potassium, and chloride in urine is a useful tool for classifying patients with volume-depleted thiazide-associated hyponatraemia (TAH) requiring fluid substitution relative to those with syndrome of inappropriate antidiuresis (SIAD)-like presentation warranting fluid restriction, according to a recent study.

Early adolescents with higher vitamin D levels at baseline appear to be at lower risk of depression, a study has found.

Treatment with retatrutide, the novel agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors, leads to marked reductions in body weight in individuals with obesity, as shown in the results of a phase II trial.